These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8299783)

  • 1. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hirsutism with the pure antiandrogen flutamide.
    Cusan L; Dupont A; Bélanger A; Tremblay RR; Manhes G; Labrie F
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):462-9. PubMed ID: 2212145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.
    Müderris II; Bayram F; Sahin Y; Keleştimur F; Tutuş A; Ayata D
    Fertil Steril; 1996 Aug; 66(2):220-2. PubMed ID: 8690105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism.
    Couzinet B; Pholsena M; Young J; Schaison G
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):157-62. PubMed ID: 8370128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
    Moghetti P; Castello R; Negri C; Tosi F; Magnani CM; Fontanarosa MC; Armanini D; Muggeo M
    Fertil Steril; 1995 Sep; 64(3):511-7. PubMed ID: 7641903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.
    Calaf J; López E; Millet A; Alcañiz J; Fortuny A; Vidal O; Callejo J; Escobar-Jiménez F; Torres E; Espinós JJ;
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3446-52. PubMed ID: 17566093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome.
    Pucci E; Genazzani AD; Monzani F; Lippi F; Angelini F; Gargani M; Barletta D; Luisi M; Genazzani AR
    Gynecol Endocrinol; 1995 Sep; 9(3):221-8. PubMed ID: 8540292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome.
    Falsetti L; De Fusco D; Eleftheriou G; Rosina B
    Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
    Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
    Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
    Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hirsutism--a low dose spironolactone therapy.
    Vĕtr M
    Acta Univ Palacki Olomuc Fac Med; 1989; 122():239-45. PubMed ID: 2530821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.
    Moghetti P; Castello R; Zamberlan N; Rossini M; Gatti D; Negri C; Tosi F; Muggeo M; Adami S
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1250-4. PubMed ID: 10199763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.